BAL PHARMA LTD. - Statement Of Investor Compliants_30.09.2017

Ref: Regulation 13(3) of SEBI (LODR) Regulations, 2015.<BR> <BR> With reference to the above, the following is the statement pertaining to investor grievances for the quarter ended 30.09.2017.<BR> <BR> Serial No. Details of Investor Complaints No. Of Complaints<BR> 1 Pending as on 01.07.2017. 0<BR> 2 Received during the quarter ended 30.09.2017. 2<BR> 3 Disposed off during the quarter ended 30.09.2017.2<BR> 4 Unresolved at the quarter ended 30.09.2017. 0<BR> <BR> Please take the same on record.<BR> <BR> Thanking You.<BR>